The lawsuit’s outcome could have major implications for millions of Americans, especially after Congress voted in 2025 to ...
First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...
To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...
The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...
Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...
The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the announcement was light on details.
Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work requirements, the Trump administration announced Thursday, signaling how ...
This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...
Senators call for a review of TrumpRx by the Office of Inspector General at the Department of Health and Human Services.
How big of a role do our genes play in our lifespan? Quite a bit more than previously thought, a new study suggests.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results